1 Apos® is FDA-cleared for treating knee osteoarthritis and can be for general wellness to support conditions of the hips and lower back. Generally, people with severe balance problems are, unfortunately, not suitable for the treatment. In a clinical trial there were no significant adverse events reported.
2 A newly released real-world study published in Musculoskeletal Care, showed that Apos® treatment helped knee-surgery candidates avoid surgery and improved clinical outcomes, such as reductions in pain, for three years.